endocrine-metabolic disease
Conditions
Interventions
None listed
Sponsors
Osaka University
TEIJIN PHARMA LIMITED
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects with endocrine-metabolic disease (diabetes, acromegaly and Cushing disase), and the study was approved by the human ethics committee of Osaka University and a written informed consent was obtained from eac subject.
Exclusion criteria
Exclusion criteria: Subjects under domiciliary oxygen therapy and/or nasal CPAP therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the prevarence and severity of sleep apnea syndrome in patients with endocrine-metabolic disease | — |
Countries
Japan
Outcome results
None listed